TrialNCT04880642Phase 3Completed
A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
Study sponsor: Vicore Pharma AB
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2022-04-25Actual
Enrollment · participants272Actual
Source updated2023-12-14Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.